236 related articles for article (PubMed ID: 36906230)
1. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments.
Sun T; Jiang C
Adv Drug Deliv Rev; 2023 May; 196():114773. PubMed ID: 36906230
[TBL] [Abstract][Full Text] [Related]
2. Stimuli-responsive nanoplatforms for antibacterial applications.
Huang Y; Zou L; Wang J; Jin Q; Ji J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
[TBL] [Abstract][Full Text] [Related]
3. Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy.
Jia R; Teng L; Gao L; Su T; Fu L; Qiu Z; Bi Y
Int J Nanomedicine; 2021; 16():1525-1551. PubMed ID: 33658782
[TBL] [Abstract][Full Text] [Related]
4. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
[TBL] [Abstract][Full Text] [Related]
5. Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release.
Raza A; Rasheed T; Nabeel F; Hayat U; Bilal M; Iqbal HMN
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901827
[TBL] [Abstract][Full Text] [Related]
6. Enzyme responsive drug delivery systems in cancer treatment.
Shahriari M; Zahiri M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
J Control Release; 2019 Aug; 308():172-189. PubMed ID: 31295542
[TBL] [Abstract][Full Text] [Related]
7. Advances in intelligent-responsive nanocarriers for cancer therapy.
Tian M; Xin X; Wu R; Guan W; Zhou W
Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
[TBL] [Abstract][Full Text] [Related]
8. The Intracellular and Extracellular Microenvironment of Tumor Site: The Trigger of Stimuli-Responsive Drug Delivery Systems.
Jing X; Hu H; Sun Y; Yu B; Cong H; Shen Y
Small Methods; 2022 Mar; 6(3):e2101437. PubMed ID: 35048560
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
10. Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs.
Ahmed T; Liu FF; Lu B; Lip H; Park E; Alradwan I; Liu JF; He C; Zetrini A; Zhang T; Ghavaminejad A; Rauth AM; Henderson JT; Wu XY
Mol Pharm; 2022 Jun; 19(6):1722-1765. PubMed ID: 35587783
[TBL] [Abstract][Full Text] [Related]
11. Preparation and application of pH-responsive drug delivery systems.
Ding H; Tan P; Fu S; Tian X; Zhang H; Ma X; Gu Z; Luo K
J Control Release; 2022 Aug; 348():206-238. PubMed ID: 35660634
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicines for Subcellular Targeting: The Mitochondrial Perspective.
Oladimeji O; Akinyelu J; Singh M
Curr Med Chem; 2020; 27(33):5480-5509. PubMed ID: 31763965
[TBL] [Abstract][Full Text] [Related]
13. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
Sa P; Sahoo SK; Dilnawaz F
Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
[TBL] [Abstract][Full Text] [Related]
14. The Smart Drug Delivery System and Its Clinical Potential.
Liu D; Yang F; Xiong F; Gu N
Theranostics; 2016; 6(9):1306-23. PubMed ID: 27375781
[TBL] [Abstract][Full Text] [Related]
15. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
Li L; Yang WW; Xu DG
J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
[TBL] [Abstract][Full Text] [Related]
16. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy.
Zhang Y; Li J; Pu K
Biomaterials; 2022 Dec; 291():121906. PubMed ID: 36395660
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs.
Raza F; Siyu L; Zafar H; Kamal Z; Zheng B; Su J; Qiu M
Curr Pharm Des; 2022; 28(5):380-394. PubMed ID: 34727851
[TBL] [Abstract][Full Text] [Related]
20. Photo-triggered polymer nanomedicines: From molecular mechanisms to therapeutic applications.
Beauté L; McClenaghan N; Lecommandoux S
Adv Drug Deliv Rev; 2019 Jan; 138():148-166. PubMed ID: 30553952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
